Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study
Research output: Contribution to journal › Article › peer-review
31Citations
(Scopus)
8Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study'. Together they form a unique fingerprint.